Chicago / Edinburgh
LATEST FROM IPOX®

News

News and updates from IPOX®, including media mentions, interviews, research and press releases.

Reuters: IPOX® Research Associate Lukas Muehlbauer Comments on Strong IPO Market and Jefferson Capital Debut

Reuters: IPOX® Research Associate Lukas Muehlbauer Comments on Strong IPO Market and Jefferson Capital Debut

In a Reuters article covering the strong market debut of Jefferson Capital, IPOX® Research Associate Lukas Muehlbauer provided commentary on the recovering U.S. IPO market. He noted the rebound is likely to be selective, "led by high-quality and long-anticipated issuers." Muehlbauer explained that an initial trading "pop" is part of the market's "healthy process of price discovery" to establish a sustainable price. Read more in the full article on the IPOX® website.

Bloomberg: IPOX® Research Associate Lukas Muehlbauer on European IPO Market Challenges

Bloomberg: IPOX® Research Associate Lukas Muehlbauer on European IPO Market Challenges

In a recent Bloomberg article, IPOX® Research Associate Lukas Muehlbauer commented on the challenging European IPO market. Highlighting the recent withdrawal of several listings, Muehlbauer noted that investor appetite is particularly low for private equity exits where proceeds do not benefit the company. He stated, “Deals that are essentially existing owners cashing out are proving to be a tough sell.” Read more about his analysis of the current market sentiment on our blog.

IPOX® Announcement: IPOX® 100 U.S. (FPX) Surges to New All-Time High, Up +21% Year-to-Date

IPOX® Announcement: IPOX® 100 U.S. (FPX) Surges to New All-Time High, Up +21% Year-to-Date

The IPOX® 100 U.S. Index (ETF: FPX) is opening at a new all-time high, extending its year-to-date gain to +21%. This surge is driven by positive market sentiment, end-of-quarter positioning, and reassuring inflation comments from the FED. Other key indexes, including the IPOX® International (FPXI) and IPOX® 100 Europe (FPXE), also closed at multi-year highs, reflecting broad strength across the IPOX® portfolio and its position as the gold standard for IPOs.

Reuters: IPOX® Research Associate Lukas Muehlbauer Comments on Wealthfront's IPO Filing

Reuters: IPOX® Research Associate Lukas Muehlbauer Comments on Wealthfront's IPO Filing

IPOX® Research Associate Lukas Muehlbauer commented on the news of Wealthfront Corporation's confidential U.S. IPO filing in a Reuters article on June 23, 2025. He noted that the move is consistent with a recent positive trend in the market, stating, "Wealthfront's IPO plans fit in with the recent uptick of successful U.S. IPOs, particularly from sectors insulated from trade and supply chain volatility."

Reuters: IPOX® VP Kat Liu Comments on Slide's Blockbuster IPO

Reuters: IPOX® VP Kat Liu Comments on Slide's Blockbuster IPO

In a Reuters article on Slide Insurance's $2.6 billion IPO, IPOX® Vice President Kat Liu provided expert insights. Liu commented on the firm's niche strategy in high-risk coastal markets and the appeal of insurer IPOs due to predictable cash flows. She also offered perspective on potential governance concerns at the newly public company, highlighting IPOX®'s expertise in analyzing new listings and market trends in the global financial sector.

Bloomberg: IPOX® CEO Josef Schuster on Potential Mega-IPO of Vale’s Metals Unit

Bloomberg: IPOX® CEO Josef Schuster on Potential Mega-IPO of Vale’s Metals Unit

In a recent Bloomberg feature, IPOX® Founder and CEO Josef Schuster analyzed the potential IPO of Vale SA’s base metals unit. He noted a listing based on its $25 billion valuation could be the most valuable mining stock debut since Glencore Plc in 2011, stating it “would definitely rank amongst the top 10 mining IPOs.” This commentary underscores the historic scale of the potential offering in the global materials sector. Read more here.

Reuters: IPOX® Research Associate Muehlbauer on Kilcoy's U.S. IPO Filing

Reuters: IPOX® Research Associate Muehlbauer on Kilcoy's U.S. IPO Filing

IPOX® Research Associate Dr. Lukas Muehlbauer commented on the U.S. IPO filing of Australian meat producer Kilcoy Global Foods. The article discusses the recent resurgence in the U.S. IPO market and notes that Kilcoy's listing will be a significant indicator of investor appetite for companies with intricate global supply chains.

Reuters: IPOX® VP Kat Liu on Chime's Strong IPO Performance and the Reopening of the Fintech IPO Window

Reuters: IPOX® VP Kat Liu on Chime's Strong IPO Performance and the Reopening of the Fintech IPO Window

In a Reuters article covering Chime’s IPO, IPOX® VP Kat Liu, provided expert commentary on the implications of the company’s strong market reception. Ms. Liu noted that the performance of a high-profile "unicorn" like Chime is being closely watched and could encourage other private fintech companies to move forward with their own public offerings.

THE IPOX® NEWSLETTERS

Stay ahead of the next listing.

Research and insight from the global new listings market.

Explore our newsletters